AliveDx

Most lab directors track throughput. Fewer track how much of their team's time is actually tied to the instrument itself. In an independent CapRock benchmark study of MosaiQ® instrument, a full 9 hour shift processing 660 samples required just 21 minutes of instrument specific operator interaction. When staffing is tight, that's the number that matters. See the full benchmark study. *This product is not available for sale, distribution, or clinical use within the United States. The information contained on this report is intended exclusively for audiences outside of the United States.

One of the operational realities laboratories face today is that increasing test demand is often not matched by corresponding increases in staffing or resources. This is one reason I found the CapRock Global Benchmark Study particularly compelling. Beyond throughput metrics alone, the study evaluated how the MosaiQ® platform workflow performs from an operational standpoint, under sustained laboratory conditions—incorporating continuous sample loading, operator interaction, and workflow consistency across representative shifts. What stood out most to me was the flexibility of the workflow model. The system demonstrated the ability to support both continuous random-access loading and batch-style operation, depending on laboratory priorities and staffing models. In practice, this type of flexibility can be just as important as peak throughput specifications. The study further underscores the operational advantages of multiplex testing. Using the AiPlex® Celiac Disease panel, multiple clinically relevant antibody markers are generated simultaneously from a single sample, while minimising additional workflow steps and sample volume requirements. Independent workflow validation studies such as this help provide a more realistic understanding of how technologies integrate into day-to-day laboratory operations. The full CapRock Benchmark Study white paper and supporting scientific blog, written by Dr. Christian Fischer, M.D., M.Sc, for AliveDx, are available below. 🔗 https://lnkd.in/eBSEMrzX

As a physician, what interests me most about multiplex diagnostics is not simply throughput—it is the ability to generate more clinically meaningful information from a limited patient sample. In the CapRock Benchmark Study, the MosaiQ AiPlex® Celiac Disease panel generated four antibody results plus a Total IgA flag from approximately 20 μL of sample volume. In traditional sequential single-analyte workflows, obtaining this level of information may require substantially more sample volume, additional testing steps, and longer time to complete evaluation. This is particularly important in certain patient populations, where minimizing repeat blood draws and maximizing diagnostic insight from a limited sample can have meaningful clinical impact. What I found valuable about this evaluation was that the system was assessed under sustained, simulated real-world laboratory conditions rather than optimized demonstrations. I recently wrote a blog for AliveDx discussing the study findings, the implications of multiplex workflows, and why independent validation studies like this are so important for evaluating real-world laboratory performance. You can access the full CapRock Global Benchmark Study white paper and blog here: 🔗https://lnkd.in/d_a5DnBE

What does multiplex testing actually look like at scale? It's easy to talk about multiplex. Harder to show what it looks like across 1,943 samples in a working lab environment. First multiplex result set in 58 minutes with subsequent results delivered every 42 seconds. CapRock Global independently benchmarked MosaiQ AiPlex CD to find out. See what the study found.

Less than two weeks until we are in Prague — and we cannot wait! We are heading back to Autoimmunity 2026, 14–17 May, and you will find us at Booth #2 throughout the congress. Stop by to see LumiQ® and MosaiQ® in action, explore our autoimmune assay portfolio, and speak with our scientific and commercial team about what matters most to your laboratory. 📅 We are also offering private 1:1 meetings during the congress — book here: https://lnkd.in/gUQUKpQN 📍 Booth #2 | Prague Congress Centre | 14–17 May 2026

Still running singleplex? MosaiQ® technology delivers multiplex testing from a single assay — standardised results, scalable workflows, less complexity. A smarter workflow approach for modern laboratories.